We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ITRM market cap is 48.71M. The company's latest EPS is USD -1.3945 and P/E is -1.27.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 70k | -79k | 0 | 0 | 0 |
| Operating Income | -16.62M | -11.51M | -6.16M | -4.01M | -4.89M |
| Net Income | -3.88M | -12.36M | -7.1M | -5M | -6.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 233k | 553k | 195k | 503k | 82k |
| Operating Income | -101.83M | -31.57M | -24.34M | -29.12M | -47.39M |
| Net Income | -103.13M | -52.01M | -91.56M | -43.67M | -38.37M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.73M | 26.26M | 19.63M | 14.17M | 15.92M |
| Total Liabilities | 36.3M | 32.66M | 25.78M | 25.09M | 27.43M |
| Total Equity | 3.43M | -6.4M | -6.15M | -10.91M | -11.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 25.75M | 32.79M | 91.51M | 66.83M | 26.26M |
| Total Liabilities | 51.99M | 83.35M | 41.28M | 38.83M | 32.66M |
| Total Equity | -26.24M | -50.56M | 50.23M | 28M | -6.4M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.49M | -39.33M | -13.08M | -19.84M | -22.51M |
| Investing | 9.81M | 23.34M | 7.21M | 11.41M | 17.11M |
| Financing | 445k | 1.03M | 7.22M | 7.38M | 12.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.89M | -54.53M | -15.84M | -18.47M | -39.33M |
| Investing | 40.1M | -11k | -54.6M | 13.96M | 23.34M |
| Financing | -974k | 64.48M | 83.13M | -1.82M | 1.03M |
| Market Cap | 48.71M |
| Price to Earnings Ratio | -1.27 |
| Price to Sales Ratio | 590 |
| Price to Cash Ratio | 8.02 |
| Price to Book Ratio | -7.61 |
| Dividend Yield | - |
| Shares Outstanding | 27.52M |
| Average Volume (1 week) | 1.14M |
| Average Volume (1 Month) | 1.54M |
| 52 Week Change | 4.74% |
| 52 Week High | 3.02 |
| 52 Week Low | 0.808 |
| Spread (Intraday) | 0.4 (20.2%) |
| Company Name | Iterum Therapeutics PLC |
| Address |
200 s wacker drive chicago, illinois IL 60606 |
| Website | https://www.iterumtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
